Correct Answer: C. Retinoic acid
The clinical triad of delayed dark adaptation, gritty sensation, dry eyes (xerophthalmia), and corneal softening (keratomalacia) is pathognomonic for vitamin A deficiency. Vitamin A exists in two active forms: retinol (preformed) and retinoic acid (active metabolite). Retinoic acid is the biologically active form that binds to nuclear retinoic acid receptors (RAR and RXR) and regulates gene expression for visual pigment synthesis and epithelial cell differentiation. In the retina, vitamin A is converted to 11-cis-retinal, which combines with opsin to form rhodopsin—the visual pigment essential for low-light vision. Deficiency impairs rhodopsin regeneration, causing night blindness (nyctalopia) and delayed dark adaptation. Vitamin A also maintains the integrity of mucous membranes and epithelial tissues; its deficiency leads to squamous metaplasia of conjunctival and corneal epithelium, causing xerosis (dryness), Bitot's spots, and ultimately corneal scarring or melting (keratomalacia). In India, vitamin A deficiency remains a leading preventable cause of childhood blindness, particularly in rural populations with poor dietary intake of retinol-rich foods (liver, eggs, dairy) and carotenoid-rich vegetables. The WHO and Indian Academy of Pediatrics recommend vitamin A supplementation programs to prevent this public health crisis.
Why the other options are wrong
A. Pantothenic acid — Pantothenic acid (vitamin B5) is a component of coenzyme A and is involved in fatty acid and energy metabolism. Deficiency causes 'burning feet syndrome' and neurological symptoms, not ocular manifestations. It does not regulate visual pigment synthesis or epithelial cell differentiation, making it irrelevant to xerophthalmia or night blindness. B. Niacin — Niacin (vitamin B3) deficiency causes pellagra (dermatitis, diarrhea, dementia, death), not ocular symptoms. While niacin is involved in NAD/NADP-dependent redox reactions, it does not play a role in visual pigment formation or epithelial maintenance. The clinical presentation described is entirely inconsistent with niacin deficiency. D. Riboflavin — Riboflavin (vitamin B2) deficiency causes angular cheilitis, glossitis, and corneal vascularization (not softening or xerosis). While riboflavin is a cofactor for flavoproteins involved in oxidative metabolism, it does not regulate retinoid metabolism or visual pigment synthesis. Riboflavin deficiency does not produce the characteristic night blindness or keratomalacia seen in vitamin A deficiency.
High-Yield Facts
- Night blindness (nyctalopia) is the earliest clinical sign of vitamin A deficiency and occurs because 11-cis-retinal cannot be regenerated from all-trans-retinal without adequate vitamin A.
- Xerophthalmia progression: night blindness → conjunctival xerosis → Bitot's spots → corneal xerosis → corneal softening (keratomalacia) → permanent blindness if untreated.
- Retinoic acid is the active metabolite that binds nuclear receptors (RAR/RXR) and regulates transcription of genes for visual pigments, mucins, and keratins—essential for epithelial cell differentiation.
- Keratomalacia (corneal softening and melting) is an ophthalmologic emergency in vitamin A deficiency and is a leading preventable cause of childhood blindness in India and sub-Saharan Africa.
- Indian DOC for vitamin A deficiency: high-dose vitamin A supplementation (200,000 IU orally or IM) on days 1, 2, and 14 per WHO/IAP guidelines; prevention via fortified foods and dietary diversification.
Mnemonics
NIGHT BLINDNESS = Vitamin A Night blindness is the earliest sign of vitamin A deficiency because rhodopsin regeneration requires 11-cis-retinal. Remember: 'A' for 'Adaptation' (dark adaptation) and 'A' for 'Antioxidant' (vitamin A protects epithelial tissues). XEROPHTHALMIA STAGES (VAD) XN (night blindness) → X1A (conjunctival xerosis) → X1B (Bitot's spots) → X2 (corneal xerosis) → X3 (corneal ulceration/keratomalacia) → XS (corneal scarring/blindness). Each stage is reversible until X3.
NBE Trap
NBE may pair vitamin A deficiency with "retinoic acid" to test whether students confuse the active metabolite (retinoic acid) with the dietary precursor (retinol) or with other B vitamins that also affect vision (riboflavin causing corneal vascularization). The trap is that students may incorrectly choose riboflavin because corneal involvement is mentioned, forgetting that riboflavin causes vascularization, not softening.
Clinical Pearl
In rural India, a child presenting with night blindness and dry eyes should immediately raise suspicion for vitamin A deficiency—a condition that can progress to irreversible blindness within weeks if supplementation is delayed. Early recognition and high-dose vitamin A therapy can prevent permanent vision loss and is a cornerstone of pediatric preventive medicine in resource-limited settings.
_Reference: Harper's Illustrated Biochemistry Ch. 30 (Vitamins); KD Tripathi Pharmacology Ch. 61 (Vitamins); Robbins Pathology Ch. 8 (Nutritional Deficiencies)_